Concepedia

Peter Vink

PV

31

Publications

2.2K

Citations

25

H-Index

1980

Active since

Affiliations

University of Maryland, Baltimore(Current)

GlaxoSmithKline (United States)

Emory University

GlaxoSmithKline (Belgium)

Centers for Disease Control and Prevention

Peter Vink is an author at University of Maryland, Baltimore specializing in medicine, vaccination, and immunology.

ORCID

Top concepts

Publications per year

1980–2019

31

Publications

31

Safety and Immunogenicity of 26-Valent Group A Streptococcus Vaccine in Healthy Adult Volunteers

Shelly McNeil, Scott A. Halperin, Joanne M. Langley et al. · Clinical Infectious Diseases · 2005 · 304 citations · Full text

Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant: A Phase 3, Randomized Clinical Trial

Peter Vink, Josep Ramón, Ana Sánchez‐Fructuoso et al. · Clinical Infectious Diseases · 2019 · 185 citations · Full text

Novel immunoregulatory functions of phenotypically distinct subpopulations of CD4+ cells in the human neonate.

Loran T. Clement, Peter Vink, Grace Bradley · The Journal of Immunology · 1990 · 143 citations · Full text

Impact of zidovudine use on risk and risk factors for perinatal transmission of HIV

R. J. Simonds, Richard W. Steketee, Steven Nesheim et al. · AIDS · 1998 · 132 citations

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in patients with solid tumors, vaccinated before or during chemotherapy: A randomized trial

Peter Vink, Ignacio Delgado Mingorance, C. Maximiano Alonso et al. · Cancer · 2019 · 112 citations · Full text

Rows per page

1–5 of 31